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Comparison of Isotope-labeled Amino Acid
Incorporation Rates (CILAIR) Provides a
Quantitative Method to Study Tissue
Secretomes*□S
Han Roelofsen‡§, Martijn Dijkstra‡, Desiree Weening‡, Marcel P. de Vries‡,
Annemieke Hoek¶, and Roel J. Vonk‡
Adipose tissue is an endocrine organ involved in regula-
tion of whole-body energy metabolism via storage of lip-
ids and secretion of various peptide hormones (adipo-
kines). We previously characterized the adipose tissue
secretome and showed that [13C]lysine incorporation into
secreted proteins can be used to determine the origin of
identified proteins. In the present study we determined
the effect of insulin on the secretome by comparing in-
corporation rates of 13C-labeled lysine in the presence
and absence of insulin. Human visceral adipose tissue
from one patient was divided over six dishes. After sub-
sequent washes to remove serum proteins, [13C]lysine-
containing medium was added. Three dishes also re-
ceived 60 nM insulin. The other three were controls. After
72 h of culture, media were collected and processed sep-
arately, involving concentration by ultrafiltration and frac-
tionation by SDS-PAGE followed by in-gel digestion of
excised bands and LC-MS/MS analyses. The obtained
spectra were used for database searching and calculation
of heavy/light ratios. The three control data sets shared
342 proteins of which 156 were potentially secreted and
contained label. The three insulin-derived data sets
shared 361 proteins of which 141 were potentially se-
creted and contained label. After discarding secreted pro-
teins with very low label incorporation, 121 and 113 pro-
teins remained for control and insulin data sets,
respectively. The average coefficient of variation for con-
trol triplicates was 10.0% and for insulin triplicates was
18.3%. By comparing heavy/light ratios in the absence
and presence of insulin we found 24 up-regulated proteins
and four down-regulated proteins, and 58 proteins
showed no change. Proteins involved in the endoplasmic
reticulum stress response and in extracellular matrix re-
modeling were up-regulated by insulin. In conclusion,
comparison of isotope-labeled amino acid incorporation
rates (CILAIR) allows quantitative assessment of changes
in protein secretion without the need for 100% label in-
corporation, which cannot be reached in differentiated
tissues or cells. Molecular & Cellular Proteomics 8:
316–324, 2009.
Adipose tissue plays an important role in the development
of energy metabolism-related diseases such as metabolic
syndrome and type 2 diabetes. Especially visceral adipose
tissue has been implicated in the development of these dis-
eases (1–3). Adipose tissue is an endocrine organ involved in
the regulation of whole-body energy metabolism via storage
of lipids and secretion of peptide hormones (adipokines) such
as leptin, adiponectin, visfatin, and retinol-binding protein-4
(1, 2, 4). Besides adipocytes, adipose tissue contains endo-
thelial cells, macrophages, and fibroblasts that may modulate
the overall peptide secretion pattern via cross-talk between
the various cell types. Factors secreted by macrophages have
been shown to induce changes in the secretion of adipokines,
free fatty acids, and glucose uptake by murine 3T3-L1 adipo-
cytes (5). On the other hand, the adipocyte-derived hormone
leptin has been shown to activate macrophages to produce
tumor necrosis factor-, which can be inhibited by adiponec-
tin (6). These interactions between cells from the stromal
fraction and adipocytes are important for physiological func-
tions of adipose tissue, and deregulation of this cross-talk is
regarded as an important mechanism leading to insulin resist-
ance and type 2 diabetes (7–10). By studying the tissue as a
whole rather than adipocytes alone, this cross-talk is pre-
served. To study hormonal regulation of the human adipose
tissue secretome, a quantitative proteomics approach that is
compatible with tissue culture is needed. Here we describe a
newly developed quantitative method, comparison of isotope-
labeled amino acid incorporation rates (CILAIR),1 that is es-
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pecially suitable for use in combination with tissue culture. To
obtain relevant proteomics data when using tissue culture as
a model, several difficulties have to be overcome. The pres-
ence of serum proteins inside tissue pieces that slowly diffuse
into the culture medium and the presence of intracellular
proteins that are released from damaged cells can dramati-
cally influence the dynamic range of the sample. This will
affect detection of low abundance secreted proteins. Also the
relevance of identified proteins may be difficult to assess if the
source (secreted, serum, or intracellular) is not clear. We have
shown previously that incorporation of 13C-labeled lysine in
secreted proteins can be used for validation of the origin
(tissue or serum) of detected proteins (11). Proteins that con-
tain label are synthesized by the tissue and are not derived
from serum. In the present study we assessed whether com-
paring 13C-labeled lysine incorporation into newly synthe-
sized secreted proteins at a fixed culture period could serve
as a reliable method to assess insulin-induced changes in
protein expression. Insulin is well known for its regulatory role
in energy metabolism and has profound effects on protein
synthesis (12). We show that the CILAIR method allows quan-
titative assessment of changes in protein secretion without
the need for 100% label incorporation. This makes CILAIR a
good alternative for stable isotope labeling with amino acids
in cell culture (SILAC) (13, 14) for which complete labeling of
cells is essential. However, this cannot be reached in differ-
entiated tissues or cells. In addition to relative quantification
of changes in protein expression, CILAIR provides information
on synthesis rates and on the source of secreted proteins.
EXPERIMENTAL PROCEDURES
Adipose Tissue Culture—A human omental adipose tissue explant
was obtained from a women (age, 39 years; body mass index, 21.7)
undergoing laparotomy to remove an intramural myoma. The study
had the approval of the local ethics committee.
The adipose tissue culture protocol is described in Alvarez-Llamas
et al. (11). Briefly adipose tissue explants were transported from the
operating room to the laboratory in transport buffer (PBS, 5.5 mM
glucose, 50 g/ml gentamicin) at room temperature. The following
procedures were carried out under a laminar flow hood using sterile
equipment. Immediately upon arrival, the tissue was transferred to a
Petri dish containing 20 ml of PBS and was finely minced in 20–
80-mg pieces using scissors. The tissue pieces were extensively
washed with 400 ml of PBS over a filter containing sterile cotton
bandage fabric. Thereafter the tissue pieces were transferred to a
75-cm2 culture flask containing 200 ml of PBS and were gently
shaken for a short period. Next the contents of the flask was poured
over the filter, and the tissue pieces were washed with 300 ml of warm
PBS (37 °C). The tissue pieces were transferred to a tube containing
50 ml of PBS and centrifuged for 1 min at 277  g at room temper-
ature to remove red blood cells and debris. The tissue was then
removed from the tube, and the weight was determined. To six dishes
with 1.2 g of tissue each, 12 ml of lysine-free M199 medium (reference
number 22340 Lys-free, Invitrogen) supplemented with 50 g/ml
gentamicin was added to deplete lysine from other sources (blood in
the tissue). The dishes were incubated at 37 °C at 5% CO2. The
medium was renewed after 1, 18.5, 22.5, and 26.5 h. After the last
wash (time point, 26.5 h), all six dishes received fresh M199 medium
containing 70 mg/liter 13C-labeled lysine (L-[13C6,
14N2]lysine (Invitro-
gen)). To three of the six dishes also 60 nM human insulin was added.
Tissues were maintained in culture for an additional 72 h to allow
incorporation of the label into newly synthesized proteins. Thereafter
media were collected and stored at 80 °C until analysis.
Protein Identification by LC-MS/MS—Eleven milliliters of adipose
tissue culture medium was concentrated by ultrafiltration (Vivaspin
15R, 3-kDa cutoff). This concentrated sample was further concen-
trated by ultrafiltration (Microcon, 3 kDa, Millipore) to a final volume of
approximately 40 l. Proteins present in the concentrated adipose
tissue medium sample were fractionated by SDS-PAGE on a 4–12%
bis-Tris gel with a MOPS buffer system according to the manufactur-
er’s protocol (NuPAGE-Novex, Invitrogen). Protein separation oc-
curred for 50 min at 200 V, and visualization of bands was performed
overnight by Coomassie Brilliant Blue G-250-based staining (Page-
Blue Staining Solution, Fermentas). The whole lane was excised into
25 bands that were processed for tryptic digestion. Each band was
cut into small pieces and stored at 20 °C until analysis. Then they
were washed in ultrapure water and dehydrated in ACN. In-gel re-
duction with dithiothreitol (for 1 h at room temperature) and carbam-
idomethylation with iodoacetamide (for 45 min at room temperature in
the dark) were performed. Gel pieces were subsequently washed with
FIG. 1. The CILAIR work flow. To six culture dishes with human
adipose tissue pieces [13C]lysine was added. Three dishes also re-
ceived 60 nM insulin. The tissues were cultured for 72 h. After the
incubation was completed, media were collected and prepared sep-
arately for LC-MS/MS analyses. Samples were concentrated by ul-
trafiltration and subsequently fractionated by SDS-PAGE. After LC-
MS/MS analyses, proteins were identified, and heavy/light ratios were
determined. In this way three control data sets and three data sets
from insulin-treated tissue were obtained. The control and insulin-
treated data sets were compared to obtain one data set for each
condition with proteins that contain label and were identified in all
three dishes. Subsequently the overlap between these data sets was
determined, and the -fold change values were calculated for each
protein by dividing their heavy/light ratios in the insulin and control
data set.
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ultrapure water, 50% ACN, and pure ACN. Next 0.4 g of modified
trypsin (Promega) in 20 mM ammonium bicarbonate was added, and
gel pieces were allowed to rehydrate on ice for 20 min. Digestion was
carried out overnight at 37 °C.
Separation of the resulting tryptic peptide mixtures was performed
by nanoscale reversed-phase LC-MS/MS. The Agilent 1100 nano-
flow/capillary LC system was equipped with a trapping column (5 
0.3 mm, C18RP) (Dionex/LC Packings, Amsterdam, The Netherlands)
and a nanocolumn (150  0.075 mm, C18PepMap) (Dionex/LC Pack-
ings). Peptides mixtures were injected into the trapping column at a
flow rate of 20 l/min (0.1% formic acid (FA)). After 5 min the trapping
column was switched into the nanoflow system, and the trapped
peptides were separated using the nanocolumn at a flow rate of 0.3
l/min in a linear gradient elution from 95% A (0.1% FA) to 50% B
(90% ACN, 0.1% FA) in 53 min followed by an increase up to 80% B
in 3 min. The eluting peptides were on-line electrosprayed into the
QStar XL hybrid ESI quadrupole time-of-flight tandem mass spec-
trometer (ESI-qQTOF-MS/MS, Applied Biosystems, Framingham,
MA; MDS Sciex, Concord, Ontario, Canada) provided with a nano-
spray source equipped with a Proxeon stainless steel needle
(25-m diameter). Typical values for emitter voltage were 2.25 kV in
positive ion mode. Analyst QS 1.1 software (Applied Biosystems)
was used for data acquisition in the positive ion mode typically with
a selected mass range of 300–1500 m/z. Peptides with 2 to 4
charge states were selected for tandem mass spectrometry, and
the time of summation of MS/MS events was set to be 2 s. The
three most abundant charged peptides above a 30-count threshold
were selected for MS/MS and dynamically excluded for 30 s with
30-ppm mass tolerance.
Data Analyses—ProteinPilot 2.0 software (Applied Biosystems) was
used to generate peak lists and as search engine to identify proteins
from the mass spectrometric data sets using the UniprotKB/Swiss-
Prot database (release 54, January 2008, 276,256 entries). The search
engine makes use of the ParagonTM algorithm (15). Search parame-
ters such as modifications, substitutions, cleavage events, and mass
tolerance are modeled with probabilities and do not need discrete
user-controlled settings. Options that were chosen within the pro-
gram were: label, Lys 6; Cys alkylation with iodoacetamide; diges-
tion with trypsin; gel-based identification; species, Homo sapiens;
identification focus for biological modifications; thorough search. The
software automatically detects the heavy/light peak pairs and calcu-
lates the heavy/light ratios based on the peak areas. The automatic
correction for mixing errors (normalization to median) when perform-
ing SILAC was turned off. Identifications with a probability score
higher than 95% were included in the results list. When the heavy/
light ratio of a protein differed more than two standard deviations from
the average ratio of the triplicate, spectra were manually inspected for
correct label detection and, if necessary, corrected. This was the case
for eight proteins in the control data set and one in the insulin data set.
The statistical analysis and visualization was performed in R, a lan-
guage for statistical computing and graphics. We analyzed ratios on
a logarithmic scale.
Classification of identified proteins as potentially secreted was per-
formed by SecretomeP 2.0 (16). Those proteins with a predicted signal
peptide were considered as secreted via the classical pathway (endo-
plasmic reticulum/Golgi-dependent pathway). If no signal peptide was
predicted but the NN score exceeded the value of 0.5, proteins were
classified as secreted via the non-classical pathway. Proteins that did
not match these criteria were considered as being intracellular.
Functional interactions between up- or down-regulated proteins
were determined using STRING with the high confidence setting.
STRING is a database of known and predicted protein-protein inter-
actions derived from genomic context, high throughput experiments,































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































FIG. 2. Correlation between dishes
for label incorporation. For each con-
dition the log 13C/12C ratios of the pro-
teins detected in the dishes were plotted
against each other. The correlation coef-
ficient of the trend lines is indicated.
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A human visceral adipose tissue explant, obtained from a
lean person to assure good insulin sensitivity, was prepared
for tissue culture as described under “Experimental Proce-
dures.” The experiment was performed in triplicate to allow
assessment of variation in the outcome of the method. The
complete CILAIR work flow is depicted in Fig. 1. Tissue pieces
were equally divided over six culture dishes and were cultured
in lysine-free medium for 26.5 h with intermittent washing
steps to remove serum enclosed in the tissue pieces and to
reduce the [12C]lysine pool in the tissue. Thereafter [13C]lysine
was added to all six dishes. At this point, three dishes also
received 60 nM insulin. The tissues were cultured for an ad-
ditional 72 h. In previous experiments, this period showed
sufficient label incorporation in secreted proteins (11). After
the incubation was completed, media were collected and
prepared separately for LC-MS/MS analyses. Samples were
concentrated by ultrafiltration and subsequently fractionated
by SDS-PAGE. Twenty-five bands per lane were cut, and
in-gel digestion was performed. After LC-MS/MS analyses,
proteins were identified, and heavy/light ratios were deter-
mined. In this way three control data sets and three data sets
from insulin-treated tissue were obtained. For the three con-
trol dishes 440, 390, and 378 proteins were identified. For the
insulin-treated dishes 447, 496, and 425 proteins were iden-
tified. The control data sets were compared and showed an
overlap of 342 proteins. The data sets from the insulin-treated
dishes showed an overlap of 361 proteins. After removal of
unlabeled proteins, 213 proteins remained in the control data
set that contained label and were identified in all three dishes.
For the insulin-treated data set, 247 proteins contained label
and were detected in all three dishes (see Supplements 1 and
2 for control and insulin data sets, respectively). Unlabeled
proteins may be identified only by arginine-containing pep-
tides or may be derived from serum which, despite the vigor-
ous washing protocol, is enclosed in the tissue pieces and is
slowly released during culture. High correlation for label in-
corporation between dishes within triplicates was obtained
(Fig. 2) with correlation coefficients ranging from 0.97 to 0.98
for controls and from 0.92 to 0.94 for insulin-treated dishes.
On a log scale, the frequency distribution of the ratios ob-
served for both control and insulin data appears as a mixture
of two normal distributions (Fig. 3): one distribution for pro-
teins with heavy/light ratios lower than 1 (log 0) and the other
distribution for proteins with heavy/light ratios higher than 1
(log 0). An explanation for this mixture of distributions may be
FIG. 3. Frequency distribution of
heavy/light ratios. The figure depicts
the frequency distribution of the heavy/
light ratios observed for proteins de-
tected in control and insulin conditions.
Also the contribution of heavy/light ratios
for potentially secreted and intracellular
proteins to the overall distribution is
shown.
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provided by the presence of intracellular proteins in the cul-
ture medium. Intracellular proteins can make up more than
50% of the proteins in the medium (11). Therefore, the con-
tribution of secreted and intracellular proteins to this distribu-
tion was established using SecretomeP. The control data set
contained 155 potentially secreted proteins and 58 potentially
intracellular proteins. Of the 247 proteins in the insulin data
set, 141 were potentially secreted. For both control and insu-
lin data sets, intracellular proteins show low label incorpora-
tion and mainly contribute to the left part of the distribution
(see Fig. 3). Secreted proteins can be found in both distribu-
tions. However, the right part of the distribution (high label
incorporation) consists completely of secreted proteins.
Therefore, the mixture of two normal distributions can at least
partly be explained by the presence of intracellular proteins in
the culture media. Furthermore it is remarkable that insulin
shifts the maxima of both distributions to the right, indicating
that insulin has a stimulating effect on label incorporation for
both secreted and intracellular proteins.
To assess the variation in the measurement, the coefficient
of variation (CV) was calculated for all the proteins in the two
data sets. Because of the use of log ratios for calculating the
mean and standard deviation of the triplicates, calculation of
CVs for proteins with a mean log ratio close to 0 can return
very high CVs. Because this is not due to the measurement
but due to the way of calculation, we did not include the few
proteins with a mean log ratio between 0.5 and 0.5. Fig. 4
shows the frequency distributions of the CVs for secreted and
intracellular proteins in the control and insulin data sets. The
average CV for secreted and intracellular proteins in the con-
trol was 10.3 and 14.1%, respectively. For the insulin-treated
data sets average CV for secreted and intracellular proteins
was 17.3 and 25.9%, respectively. This indicates that intra-
cellular proteins present in the medium have on average lower
heavy/light ratios and show higher variation than secreted
proteins in both control and insulin data sets. This can be
explained by assuming that intracellular proteins are released
randomly by the tissue within the 72-h labeling period, leading
to lower label incorporation and higher variation compared
with secreted proteins. Therefore, intracellular proteins were
removed from both data sets.
In addition, a threshold heavy/light ratio was applied to
correct for false positives that are generated when small 13C
peaks have to be distinguished from noise peaks by the
software. For example, serum albumin, which is derived from
blood and not synthesized by adipose tissue, was mistakenly
detected as containing label (13C/12C ratio of 0.05 and 0.06 in
control and insulin, respectively). To avoid this problem an
arbitrarily chosen cutoff ratio of 0.15 was applied to both data
sets to obtain more relevant data. This reduces the control
and insulin data sets to 121 and 115 proteins and the average
CV to 10.0 and 18.3%, respectively.
FIG. 4. Variation in the measurement
of secreted and intracellular proteins.
The frequency of the observed variations
in label incorporation within the triplicate
(CV) was plotted for proteins that are
potentially secreted and proteins that
are potentially intracellular for control
and insulin conditions as indicated. Also
the mean CV for these groups is given.
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In Table I a list is presented showing the top 20 proteins
with highest label incorporation in the control situation. Table
II shows this list for the insulin-treated tissue. The CXC motif
chemokine 5 (CXCL5) had the highest synthesis rate of the
identified proteins in the control situation with a heavy/light
ratio within the 72-h culture period of 4.28, which is equal to
a label incorporation of 80%. Other proteins with high syn-
thesis rates were macrophage colony-stimulating factor 1
(CSF1) with a ratio of 4.09 and peptidyl-glycine -amidating
monooxygenase with a ratio of 3.74. When insulin was pres-
ent the highest synthesis rate was found for CC motif chemo-
kine 2 with a heavy/light ratio of 4.85, which equals 83% label
incorporation. Second was insulin-like growth factor-binding
protein 6 with a ratio of 4.57, and third was CSF1 with a ratio
of 4.30. The latter protein had a similar ratio (4.09) in the
control situation, indicating there was no change in synthesis
rate due to insulin. Also for CXCL5 there was no change with
ratios of 4.28 and 4.03 for control and insulin, respectively.
However, insulin-like growth factor-binding protein 6 ap-
peared up-regulated 1.34-fold by insulin because its ratio in
the control is 3.40, whereas in the insulin-stimulated tissue it
is 4.57. -Fold change values were determined for all proteins
present in both data sets. The overlap between control and
insulin data sets was 86 proteins. -Fold change factors were
calculated by dividing heavy/light ratios for the insulin condi-
tion by the corresponding values in the control data set. In Fig.
5, the -fold change values for the 86 proteins are plotted,
ranked to decreasing -fold change value. Assuming a normal
distribution significance of observed change was calculated
by Student’s t test (p  0.05) (Table III). Fifty-eight proteins
were unchanged. Twenty-four proteins were up-regulated
with the highest difference being 2.7-fold for calreticulin. Four
proteins were down-regulated. CD14 was reduced 1.6-fold.
DISCUSSION
Metabolic labeling is a very useful proteomics tool when
using tissue culture. As we have shown previously (11), it
facilitates validation of the source of the identified secreted
proteins. When proteins have incorporated the label they
should be synthesized by the tissue and not be derived from
blood present within the tissue. In the present study we show
that insulin-induced changes in the rate of label incorporation
into secreted proteins can be used as a relative measure to
quantify changes in expression. The CILAIR method proved to
be robust and reproducible with CVs ranging from 10% for the
control and 18% for insulin-treated tissue. The latter CV is
TABLE I
Secreted proteins with the highest label incorporation in the
control triplicate
AVG H/L, average heavy/light ratio; SPARC, secreted protein acidic
and rich in cysteine.
Accession
no.
Name AVG H/L CV
%
P42830 CXCL5 4.28 10.12




Q06481 Amyloid-like protein 2 3.70 9.57
O95633 Follistatin-related protein 3 3.67 3.84
P02452 Collagen -1(I) chain 3.64 1.99
P02649 Apolipoprotein E 3.61 18.10
P03956 Interstitial collagenase 3.61 15.15
P16870 Carboxypeptidase E 3.60 15.40
P02461 Collagen -1(III) chain 3.59 5.55
P05156 Complement factor I 3.58 18.51
P00751 Complement factor B 3.53 8.49
P12109 Collagen -1(VI) chain 3.53 4.04









P16035 Metalloproteinase inhibitor 2
(TIMP-2)
3.39 6.19
P09486 SPARC 3.34 8.83
P08253 72-kDa type IV collagenase
(MMP-2)
3.34 3.80
P34096 Ribonuclease 4 3.33 5.3
TABLE II
Secreted proteins with the highest label incorporation in the
insulin-treated triplicate
AVG H/L, average heavy/light ratio.
Accession
no.
Name AVG H/L CV
%
P13500 CC motif chemokine 2 (CCL2) 4.85 6.70
P24592 Insulin-like growth factor-
binding protein 6
4.57 15.46
P09603 CSF1 4.30 17.14




P16035 Metalloproteinase inhibitor 2
(TIMP-2)
4.20 14.21
P02452 Collagen -1(I) chain 4.11 11.28
P42830 CXCL5 4.03 15.34




P01034 Cystatin-C 3.74 7.54




Q08380 Galectin-3-binding protein 3.61 9.10
P02461 Collagen -1(III) chain 3.59 14.65
P05155 Plasma protease C1 inhibitor 3.58 4.38







O00391 Sulfhydryl oxidase 1 3.44 8.57
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probably somewhat higher because of the extra variation that
can be attributed to differences in the response to insulin of
the tissues in the separate dishes. To reduce variation, intra-
cellular proteins were removed from the data sets. Intracellu-
lar proteins present in the medium showed on average lower
heavy/light ratios and higher variation than secreted proteins
in both control and insulin data sets. This can be explained by
assuming that intracellular proteins are released randomly by
damaged cells in the tissue and thus do not use the full period
of 72 h for label incorporation. Furthermore intracellular pro-
teins probably have lower synthesis rates and are regulated
more by post-translational modification rather than synthesis
and degradation, whereas secreted proteins are synthesized
on demand. This implies lower heavy/light ratios for intracel-
lular proteins compared with secreted proteins.
Another issue is the time window for label incubation in
which the method can be applied. A minimal amount of label
incorporation is necessary to be able to detect the label. On
the other hand, label incorporation should not reach a 100%
before the end of the incubation period because this would
lead to an underestimation of incorporation rates. Based on
previous experiments (11), we chose for a period of 72 h.
Highest label incorporation in this period was 83% (CC
motif chemokine 2 with a heavy/light ratio of 4.85 in the
presence of insulin). Shorter incubation times may lead to
fewer proteins that incorporate label. Longer periods may lead
to more proteins with complete label incorporation. The opti-
mal label incubation time should be determined for each
tissue/cell type and condition. In addition, a threshold ratio
was applied to correct for false positives. Low label incorpo-
Proteins
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FIG. 5. Insulin-induced changes in
secreted proteins. Proteins are ranked
according to decreasing -fold change on
a log scale. Twenty-four proteins were
significantly up-regulated, four proteins
were down-regulated, and 58 showed
no change. Up- and down-regulated
proteins are listed in Table III. Signifi-
cance of changes was determined by
Student’s t test (p  0.05).
TABLE III
Secreted proteins of which expression is affected by insulin





P27797 Calreticulin (CALR, GRP60) 0.28 0.75 2.69
P30101 Protein-disulfide isomerase A3 (GRP58) 0.23 0.60 2.63
Q969H8 Interleukin-25 (IL25) 0.29 0.66 2.31
P37802 Transgelin-2 (TAGLN2) 0.17 0.38 2.28
P14314 Glucosidase 2 subunit  (PRKCSH) 0.16 0.36 2.27
P07237 Protein-disulfide isomerase A1 (P4HB) 0.27 0.61 2.24
P14625 Endoplasmin (GRP94, HSP90B1) 0.45 0.94 2.07
P07602 Proactivator polypeptide (ENSP00000350063) 1.09 2.13 1.96
P06733 -Enolase (ENO1) 0.25 0.43 1.70
P11021 78-kDa glucose-regulated protein (GRP78, HSPA5) 1.13 1.88 1.66
P23284 Peptidyl-prolyl cis-trans isomerase B (PPIB) 0.29 0.48 1.65
P24821 Tenascin (TNC) 0.98 1.49 1.52
P24592 Insulin-like growth factor-binding protein 6 (IGFBP6) 3.40 4.57 1.34
P18428 Lipopolysaccharide-binding protein (LBP) 3.17 4.22 1.33
P23141 Liver carboxylesterase 1 (SES1) 0.33 0.43 1.32
P09919 Granulocyte colony-stimulating factor (CSF3) 2.68 3.48 1.30
P22692 Insulin-like growth factor-binding protein 4 (IGFBP4) 2.86 3.66 1.28
Q08380 Galectin-3-binding protein (LGALS3BP) 2.94 3.61 1.23
P12109 Collagen -1(VI) chain (COL6A1) 3.53 4.29 1.22
P36222 CHI3L1 3.23 3.87 1.20
P00746 Complement factor D (DF) 2.72 3.18 1.17
P01033 Metalloproteinase inhibitor 1 (TIMP-1) 2.97 3.38 1.14
P05155 Plasma protease C1 inhibitor (SERPING1) 3.15 3.58 1.14
P35442 Thrombospondin-2 (THBS2) 3.05 3.29 1.08
P08123 Collagen -2(I) chain (COL1A2) 3.15 2.69 0.85
P10145 Interleukin-8 (IL8) 2.79 2.38 0.85
Q15582 TGF-induced protein ig-h3 (TGFBI) 0.57 0.47 0.82
P08571 Monocyte differentiation antigen CD14 3.51 2.17 0.62
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ration in some proteins leads to small 13C peaks that are
difficult to distinguish from noise in the spectra or noise peaks
are mistaken for 13C peaks by the software. This is e.g. the
case with hemoglobin and serum albumin, which are clearly
serum-derived but were detected as containing low levels of
label. By applying a threshold ratio of 0.15 (7.5% label incor-
poration) these proteins were removed. Of course this thresh-
old is arbitrary and may vary from experiment to experiment.
One may also choose not to apply a threshold because the
-fold change values for these proteins will most likely not
reach significance. However, with this correction a more reli-
able list of proteins that incorporated label at different rates
within the 72-h incubation period is obtained. Tables I and II
show proteins ranked according to decreasing heavy/light
ratios for control and insulin, respectively. This ranking is
equivalent with decreasing protein synthesis rates because
label incorporation rate is solely determined by the protein
synthesis rate. However, this ranking does not necessarily
refer to the relative abundance of the proteins in the medium
because CILAIR does not take into account possible break-
down. For example, the chemokine CXCL5, which had the
highest label incorporation of the proteins listed for the control
situation (Table I), may not necessarily have had the highest
abundance in the media of the proteins listed in Table I. This
depends on the turnover of this protein. However, protein
breakdown should not affect the relative quantitation of ex-
pression changes induced by insulin, assuming that break-
down of a particular protein is not influenced by insulin. There-
fore, the -fold change value, as calculated for proteins listed in
Table III, reflects the actual situation in the media under the
two conditions. In total we found 24 proteins that were sig-
nificantly up-regulated, four proteins that were down-regu-
lated, and 58 proteins that showed no change. When analyz-
ing the functional relationship of up-regulated proteins with
the protein network program STRING (17), two major func-
tional clusters can be identified (see Fig. 6). One cluster,
containing calreticulin (GRP60), 78-kDa glucose-regulated
protein (GRP78), protein-disulfide isomerase A3 (GRP58), en-
doplasmin (GRP94), protein-disulfide isomerase A1, and pep-
tidyl-prolyl cis-trans isomerase B (cyclophilin B), is involved in
modulation of the endoplasmic reticulum (ER) stress response
(18). Glucose-regulated proteins (GRPs) normally reside in the
ER and have roles as chaperones for protein folding and as
calcium-binding proteins. However, under conditions that
perturb normal ER function leading to accumulation of mis-
folded proteins in the ER, these proteins are secreted and
may function outside the cell to aid in cell survival by regulat-
ing the immune response towards stressed cells (19, 20). In
our model, chronic incubation (72 h) with a relatively high
concentration of insulin may lead to a high demand on the
protein synthesis and folding machinery causing ER stress.
The other functional cluster that was up-regulated, although
less pronounced, contains tenascin, chitinase-3-like protein 1
(CHI3L1), and TIMP-1. These proteins are involved in extra-
cellular matrix formation. Tenascin and CHI3L1 are part of the
extracellular matrix as well as type I and VI collagens that may
also be included in this group. TIMP-1 is an inhibitor of
matrix metalloproteases. Matrix metalloproteases are in-
volved in remodeling of extracellular matrix (21). As an
anabolic hormone, insulin stimulates the storage of glucose
and lipids in fat tissue in the form of triglycerides. This
implies a higher demand for storage capacity that involves
modulation of the extracellular matrix to facilitate the asso-
ciated increase in adipocyte size (22, 23).
In conclusion, CILAIR allows quantitative assessment of
changes in protein secretion. Because CILAIR is based on the
rate of label incorporation, it does not require 100% label
incorporation, which is needed for SILAC (12, 13). Complete
labeling of cells is only feasible with proliferating cell lines.
Therefore, CILAIR is especially suited for application with
differentiated cells and tissues. In addition, it provides infor-
mation on protein synthesis rates and facilitates validation of
the origin of proteins. Use of CILAIR is not limited to adipose
tissue but should also be applicable to other tissues and
differentiated cell types in culture.
* This work was supported by the Netherlands Proteomic Centre
(Project 6.3). The costs of publication of this article were defrayed in
part by the payment of page charges. This article must therefore be
FIG. 6. Functional relationships between up-regulated proteins.
Accession numbers of proteins that were increased in expression due
to the insulin treatment (Table III) were submitted to STRING to
determine their functional relationship. Two major clusters were iden-
tified that are related to the ER stress response (PP1B, HSP90B1,
calreticulin (CALR), GRP58, HSPA5, and P4HB) and to extracellular
matrix remodeling (tenascin (TNC), TIMP1, and CHI3L1). For protein
abbreviations see Table III.
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